Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer

Archives of Gynecology and Obstetrics

Volumn 283, Issue 2, 2011, Pages 335-341

  Pan, Hun Shan ^a,b,c   Lee, Shiow Lin ^a   Huang, Lee Wen ^a,b   Chen, Yen Kung ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Positron emission tomography computed tomography; Recurrent ovarian cancer; Serum tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LAPAROSCOPY; LAPAROTOMY; OVARY CANCER; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 78751705979     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1404-6     Document Type: Article

References (26)

1. Cure research.com (2008) Statistics by country for ovarian cancer. http://www.cureresearch.com/o/ovarian-cancer/stats-country.htm . Accessed 9 Apr 2008
2. MJ Garcia-Veloso M Jurado C Ceamanos JM Aramendia MP Garrastachu G Lopez-Garcia JA Richer 2007 Diagnostic accuracy of FDG PET in the follow-up of platinum sensitive epithelial ovarian carcinoma Eur J Nuc Med Mol Imaging 34 1396 1405 10.1007/s00259-007-0366-9
3. P Gu LL Pan SQ Wu L Sun G Huang 2007 CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systemic review and meta-analysis J Clin Lab Anal 21 398 405 1:CAS:528:DC%2BD1cXpvVKntQ%3D%3D 10.1002/jcla.20208 18022924
4. CJ Rustin AE Nelstrop MK Tuxen HE Lamber 1996 Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study Ann Oncol 7 361 364 1:STN:280:DyaK28zpvFCgtg%3D%3D 8805927
5. A Santillan R Garg ML Zahurak GJ Gardner RL Giuntoli DK Armstrong RE Bristow 2005 Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range J Clin Oncol 23 9338 9343 10.1200/JCO.2005.02.2582 16361633
6. ML Engelen HW de Bruijn H Hollwema KA ten Hoor PH Willemse JG Aalders AG van der Zee 2000 Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors Gynecol Oncol 78 16 20 1:STN:280: DC%2BD3czjsVKjsg%3D%3D 10.1006/gyno.2000.5811 10873403
7. Motoyama T, Watanabe H, Takeuchi S, Watanabe T, Gotoh S, Okazaki E (1990) Cancer antigen 125, carcinoembryonic antigen and carbohydrate determinant 19-9 in ovarian tumors. Cancer 66:2628-2635
8. 18F]fluoro-2-deoxy-d-glucose in oncology J Cancer Res Clin Oncol 126 560 574 1:CAS:528:DC%2BD3cXmt1Kns7k%3D 10.1007/PL00008466 11043393
9. Nakamoto Y, Saga T, Fujii S (2005) Positron emission tomography application for gynecologic tumors. Int J Gynecol Cancer 15(5):701-709
10. Cho SM, Ha HK, Byun JY, Lee JM, Kin CJ, Nam-Kong SE, Lee JM (2002) Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. Am J Roentgenol 179(2):391-395
11. S Makhija N Howden R Edwards J Kelley DW Townsend CC Meltzer 2002 Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review Gynecol Oncol 85 53 58 1:STN:280:DC%2BD387pt1ejsQ%3D%3D 10.1006/gyno.2002.6606 11925120
12. RE Bristow RL Giuntoli HK Pannu RD Schulick EK Fishman RL Wahl 2005 Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes Gynecol Oncol 99 294 300 10.1016/j.ygyno.2005.06.019 16051330
13. MM Thrall JA DeLoia H Gallion N Avril 2007 Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer Gynecol Oncol 105 17 22 10.1016/j.ygyno.2006.10.060 17208284
14. National Institutes of Health (1994) Ovarian cancer: screening, treatment and follow-up. NIH Consensus Statement 1994, vol 12, pp 1-30
15. T Meyer GJS Rustin 2000 Role of tumor markers in monitoring epithelial ovarian cancer Br J Cancer 83 1535 1538
16. T Sugiyama T Nishida K Komai, et al. 1996 Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer Int J Gynecol Obstet 54 251 256 1:STN:280:DyaK2s%2FksVGlsA%3D%3D 10.1016/0020-7292(96)02721-X
17. E Ferazzi G Zanetta D Dordoni N Berlanda R Mezzopane AA Lissoni, et al. 1997 Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring system in multicenter study Ultrasound Obstet Gynecol 10 192 197 10.1046/j.1469-0705.1997.10030192.x
18. R Forstner H Hricak CB Powell, et al. 1995 Ovarian cancer recurrence: value of MR imaging Radiology 196 715 720 1:STN:280:DyaK2Mznt1GhsA%3D%3D 7644634
19. CK Kim BK Park JY Choi BG Kim H Han 2007 Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT J Comput Assist Tomogr 31 868 875 10.1097/rct.0b013e31803e8c45 18043348
20. V De Rosa ML Mangoni de Stefano A Brunetti, et al. 1995 Computer tomography and second look surgery in ovarian cancer patient: correlation, actual role and limitations of CT scan Eur J Gynecol Concol 16 123 129
21. RE Bristow MG del Carmen HK Pannu C Cohade ML Zahurak EK Fishman RL Wahl FJ Montz 2003 Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecol Oncol 20 519 528 10.1016/S0090-8258(03)00336-6
22. J Jimenez-Bonilla A Maldonado S Morales A Salud M Zomeno J Roman J Bolen F Moya 2000 Clinical impact of 18F-FDG-PET in the suspicion of recurrent ovarian carcinoma based on elevated tumor marker serum levels Clin Positron Imaging 3 231 236 10.1016/S1095-0397(01)00053-X 11378435
23. M Murakami T Miyamoto T Iida M Tsukada M Watanabe M Shida H Maeda S Nasu S Yasuda M Yasuda M Ide 2006 Whole body positron emission tomography and tumor marker CA 125 for detection of recurrence in epithelial ovarian cancer Int J Gynecol Cancer 16 Suppl 1 99 107 10.1111/j.1525-1438.2006.00471.x 16515575
24. M Takekuma M Maeda T Ozawa K Yasumi T Torizuka 2005 Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer Int J Clin Oncol 10 17 81 10.1007/s10147-005-0489-6
25. SC Rubin WJ Hoskins TB Hakes M Markman BS Reichman D Chapman JL Lewis 1989 Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer Am J Obstet Gynecol 160 667 671 1:STN:280:DyaL1M7ptVyrsQ%3D%3D 2648838
26. 18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings Eur J Nucl Med mol Imaging 34 480 486 10.1007/s00259-006-0260-x 17089122